Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Other IgG4-RD Studies

Translational Studies

  • Glycosylation status in IgG4-RD
  • Gene Expression analysis in IgG4-RD
  • Fibrosis markers and pathways in IgG4-RD
  • The role of allergy and IgE in IgG4-RD
  • B and T cell immunology in IgG4-RD

Clinical Studies

IgG4 Study

We hope to bring you more details of an exciting commercial study sponsored by Xencor in the near future.

Clinical studies in progress

  • The role of the IgG4 MDM
  • Second line Immunosuppressant therapies in IgG4-RD
  • MRCP in PSC and IgG4-SC (MOBILISE study)
  • HLA associations in IgG4-RD (Multi-centre UK Study)
  • IgG4 and malignancy
  • IgG4 in Adult and Paediatric Primary Sclerosing Cholangitis (PSC)
  • IgG4 in Autoimmune Liver Disease
  • IgG4 in Colitis

Contributors 

The following clinicians, fellows and students have contributed to these clinical research projects;  

Dr. Emma Culver (Oxford)

Dr. Rory Peters (Oxford)

Dr George Webster (UCL)

Dr. George Goodchild (UCL)

Dr. Tamsin Cargill (Oxford)

DR. Charis Manganis (Oxford)

Dr. Emmanuel Selveraj (Oxford)

Dr. Kate Lynch (Oxford)

Dr. Nathan Atkinson (Oxford)

Dr. Astor Rodriguez (Oxford)

Dr Sinisa Savić (Leeds)

Dr David Gorard (Bucks)

Dr Nishchay Chandra (RBH)

Dr Adrian Bateman (Southampton)

Miss Antonia Hamilton-Shield 

Mr Samuel Henderson

In this section

The Bio-medical Research Council (BRC), a part of the Oxford Hospital Radcliffe Trust (OHRT), funds research and many of our staff are involved in BRC research.

Our research is funded from a variety of funders. Their support allows our research to focus on the basic and clinical research domains to accelerate knowledge translation from the bedside to the bench, and back again.